Ohio Access Score: 70.3/100
Composite of methadone OTP density, buprenorphine provider density, mental health shortage need-met %, Medicaid coverage breadth, 1115 SUD waiver status, and legal protections. How we score.
Ohio has 1,086 active NPPES enumerations across 36 cities for clinicians who commonly prescribe buprenorphine for opioid use disorder. Coverage is wider than the old X-waiver lists suggested, but availability still varies clinic to clinic. Confirm intake before you drive anywhere.
Composite analysis
Ohio falls in the lower half for treatment access pressure. Statewide capacity is closer to the median, but rural counties may still be underserved.
TAPI is a CCIWA composite. Each input is z-scored across 50 states plus DC and Puerto Rico, then combined as a weighted sum (HPSA 30%, frequent mental distress 25%, unemployment 15%, treatment density 30%, sign-flipped). The result is rescaled 0 to 100 by percentile rank. Read the full methodology.
Composite of methadone OTP density, buprenorphine provider density, mental health shortage need-met %, Medicaid coverage breadth, 1115 SUD waiver status, and legal protections. How we score.
| Component | Detail | Points |
|---|---|---|
| OTP density | 0.721 OTPs per 100K residents | 21.6 / 30 |
| Buprenorphine density | 9.21 providers per 100K | 7.4 / 20 |
| Mental health HPSA need met | 33.73% | 11.2 / 20 |
| Medicaid breadth | 5 of 5 service categories covered | 15 / 15 |
| 1115 SUD waiver | Active | 10 / 10 |
| Legal protections | Good Samaritan: Yes · Naloxone access: Yes | 5 / 5 |
| Item | Status | Notes |
|---|---|---|
| Buprenorphine covered | Yes | Prior authorization may apply |
| Methadone covered | Yes | |
| Naltrexone covered | Yes | |
| Outpatient SUD | Yes |
1115 SUD waiver: Active. IMD exclusion waived. Expires 2024-09-30 (extension application filed 2024-04-01 requesting renewal through 2029-09-30).
Cities below have at least 5 active prescribers. Smaller cities consolidate into the closest hub city for V1.